More Than Four in 10 U.S. Adults Have Fatty Liver Disease

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, Nov. 15, 2024 -- Metabolic dysfunction-associated steatotic liver disease (MASLD) prevalence is high among U.S. adults, according to a study published online Oct. 29 in Communications Medicine.

Luis Antonio Díaz, M.D., from the University of California San Diego, and colleagues assessed racial and ethnic disparities in the SLD prevalence among U.S. adults based on new 2023 nomenclature. The analysis included data from 5,532 individuals participating in the National Health and Nutrition Examination Survey (2017 to 2018).

The researchers found that the adjusted estimated prevalence of MASLD was 42.4 percent, MASLD/alcohol-associated liver disease (MetALD) 1.7 percent, and ALD 0.6 percent. For SLD, Hispanic individuals had a higher prevalence, but there were no significant differences in advanced fibrosis prevalence due to SLD among racial/ethnic groups. A higher risk for MASLD was seen among men; individuals aged 40 to 64 years and 65 years and older; Hispanic individuals; those with health insurance; those with higher body mass index (BMI), diabetes, hypertension, hypertriglyceridemia, and low high-density lipoprotein cholesterol; and use of lipid-lowering agents. Risk for MASLD was lowest for Black adults. There were independent associations observed between a higher risk for MetALD among men and higher BMI. Only health insurance was independently associated with a lower ALD risk.

"Further studies should also be conducted to determine the best threshold to determine MetALD and to provide stricter recommendations in terms of alcohol abstinence and pharmacological therapies to individuals with dual etiology," the authors write.

Several authors disclosed ties to pharmaceutical companies.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-11-16 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords